Zynex, Inc. (NASDAQ:ZYXI) has scheduled a conference call for 27th October 2020 at 4:15 PM Eastern Time to announce its 3Q20 financial results.
The conference call will also be webcast live under the investor relations section of the website www.zynex.com
Zynex, Inc. is expected to report third quarter earnings results, after market close, on Tuesday 27th October 2020. Analysts polled by Thomson Reuters anticipate third quarter income of $ 0.05 per share from revenue of $ 21.13 million. Looking ahead, the full year income are expected at $ 0.30 per share on the revenues of $ 81.48 million.
The Company Outlook
Revenue for 3Q20 are expected in a range of $ 20.00 million ~ $ 20.50 million
Full Year 2020 topline are forecasted in a range of$ 80.00 million ~ $ 81.00 million
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. It offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation (TENS), and neuromuscular electrical stimulation device; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and TENSWave, a dual channel TENS device. The company also distributes electrodes for the delivery of electrical current to the body; batteries for use in electrotherapy products; Comfortrac for cervical traction; JetStream for hot/cold therapy; and LSO Back Braces for lumbar support.